David Evans, MD
Trauma Surgery · Columbus, OHNPI 1851517031
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (53.5%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Fresenius Kabi USA, LLC accounts for 60.9% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2024 at $45,869 and has fallen 62.7% since, to $17,110 in 2025. Among trauma surgery clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 253 payments — averaging $693.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Fresenius Kabi USA, LLC$107K
- Alcresta Therapeutics, Inc.$52K
- Tetraphase Pharmaceuticals, Inc.$8K
- Grifols Shared Services North America, Inc.$5K
- GSK$2K
- BD$1K
- plus $841 from 7 others
Across 5 payments — averaging $2217.06 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Shionogi Inc$11K
- Merck$500
What the payments were for
- Consulting fees$40,62223%
- Speaking & faculty fees$93,84353%
- Travel & lodging$35,72520%
- Food & beverage$5,2293%
- Education$180%
- Gifts$220%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Fresenius Kabi USA, LLC | 175 | $106,784 |
| Alcresta Therapeutics, Inc. | 51 | $51,553 |
| Tetraphase Pharmaceuticals, Inc. | 4 | $8,452 |
| Grifols Shared Services North America, Inc. | 7 | $4,788 |
| GSK | 1 | $2,000 |
| BD | 2 | $1,042 |
| Covidien LP | 6 | $425 |
| Boston Scientific | 2 | $235 |
| TELA Bio, Inc. | 1 | $108 |
| Smith+Nephew | 1 | $29 |
| Merck | 1 | $18 |
| Portola Pharmaceuticals, LLC | 1 | $16 |
| Prytime Medical Devices, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Smoflipid$81,731
- RELIZORB$51,104
- MD-Other$13,651
- Xerava$8,430
- Thrombate III$4,654
- Omegaven$1,260
- SpyGlass Discover$235
- OviTex 2S$108
How this compares
$175,459 in reported general payments places this provider in the 95th percentile of 51 trauma surgery providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other trauma surgery in Columbus
- Keshav DeshpandeColumbus$58K
- Andrew YoungColumbus$18K
- Lindsay SteppColumbus$15K
- Brandon KielColumbus$10K
- Mohammad ChoudharyColumbus$6K
- Andrew LoudonColumbus$5K
- Audrey SpencerColumbus$4K
- Nathan MoweryColumbus$4K
- Lauren SmithColumbus$2K
- Ariel RodgersColumbus$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.